DNA treatment cuts bad cholesterol by nearly 50% without statins
3 days ago
Researchers have designed a new DNA-based treatment that targets PCSK9, a protein closely tied to high LDL cholesterol and atherosclerosis. Their most effective molecule reduced PCSK9 protein by 87% in human liver cells and lowered cholesterol by 47% in genetically modified mice after a single injection.
phone_android📱 Use Epelcon on Your PhoneFaster. Always with you. Install the new Epelcon Mobile App v3.1.0 and access all 19 modules from your Android phone — Wallet, Jobs, Property, Diet Plans, Courses, Blog & more.Get the App
Advertise With Us!
Promote your brand, products or services across our homepage, shop, blog, email newsletters & social media channels.
This website uses cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking “Accept”, you consent to our use of cookies.